People who used cannabis had brain connection patterns that looked more like those of …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingTHCSafetyPolicyPain Why This Matters Clinicians should understand that this research could shift…
Germany Bans Cannabis Flowers from GKV and Mandates Six-Month Trial for Extracts
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicySafetyMental HealthPainAnxietyResearchIndustry Why This Matters Germany's removal of cannabis flowers from…
Day 7 ALJ Hearing: Pain Physician Critiques State Medical Marijuana System
The state medical marijuana system lacks the standardized dosing and safety monitoring of FDA-approved drugs, creating challenges for clinicians. This regulatory gap complicates evidence-based prescribing guidance for patients using cannabis for pain.…
CBDa Benefits: What the Research Says in 2026 – Hemp Flower Co.
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchHempCBDAnxietyPainSleepSafety Why This Matters Clinicians should understand that CBDa (cannabidiolic acid)…
This syndrome linked to heavy cannabis use is often misdiagnosed
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. SafetyTHCResearchNeurologyPainMental HealthDosing Why This Matters Clinicians need to recognize cannabinoid…
Resomelagon shows reduced inflammation and joint damage in osteoarthritis model
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchPainAgingCBDSafetyIndustryNeurology Clinical Summary A novel cannabinoid-based compound called resomelagon…
Navigating the Complexities of Medical Cannabis Use Among Older Adults
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainAnxietyAgingSafetyResearchDosingNeurology Why This Matters Clinicians need evidence-based guidance on cannabis…
Curaleaf International launches CPD-accredited medical cannabis education platform
Curaleaf International has launched a CPD-accredited medical cannabis education platform to support clinicians. This platform provides structured learning pathways to improve cannabis clinical knowledge. It addresses the critical need for accredited…
85% of U.S. Healthcare Professionals Believe Cannabis Has Medical Utility
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchPolicyPainAnxietyMental HealthSafetyDosing Why This Matters Healthcare professionals' widespread…
DEA’s Own Pharmacologist Undercuts Marijuana Rescheduling Order
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchNeurologyMental HealthSafetyIndustryPain Why This Matters A DEA pharmacologist's testimony suggesting…